NCT00316563 2010-02-09Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot StudyAHS Cancer Control AlbertaPhase 2 Completed80 enrolled